January 30, 2024 · Form 4 insider transaction
Aghion Daniel bought 3,750 shares of Oramed Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 937 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.